Download PDF
Hamostaseologie 2010; 30(S 01): S148-S149
DOI: 10.1055/s-0037-1619098
Communication
Schattauer GmbH

Erfolgreiche frühe Prophylaxe bei hohem Inhibitorrisiko

Eine FalldarstellungSuccessful early prophylaxes in high inhibitor riskA patient demonstration
A. Bade
1   Hämostaseologische Ambulanz der Prof.-Hess-Kinderklinik, Klinikum Bremen-Mitte
,
C. Moorthi
1   Hämostaseologische Ambulanz der Prof.-Hess-Kinderklinik, Klinikum Bremen-Mitte
,
K. Haubold
1   Hämostaseologische Ambulanz der Prof.-Hess-Kinderklinik, Klinikum Bremen-Mitte
,
C. Niekrens
2   Klinik für Kinder- und Jugendmedizin, Klinikum Delmenhorst
,
G. Auerswald
1   Hämostaseologische Ambulanz der Prof.-Hess-Kinderklinik, Klinikum Bremen-Mitte
› Author Affiliations
Further Information

Publication History

Publication Date:
23 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • Literatur

  • 1 Gouw SC, van der Bom JG, van den Berg HM. Treatment related risk factorsof inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood 2007; 109: 4648-4654.
    CrossrefPubMedSearch in Google Scholar
  • 2 Kreuz W, Escuriola-Ettingshausen C, Auerswald G. Inhibitors in haemophilia A – Ongoing research and clinical practice. European Haematology 2008; 14-20.
    PubMedSearch in Google Scholar
  • 3 Kurnik K, Bidlingmaier C, Engl W. et al. New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development. Haemophilia 2010; 16: 256-262.
    CrossrefPubMedSearch in Google Scholar
  • 4 Mancuso ME, Graca L, Auerswald G, Santagostino E. Haemophilia care in children – benefits of early prophylaxis for inhibitor prevention. Haemophilia 2009; 15 (Suppl. 01) 8-14.
    CrossrefPubMedSearch in Google Scholar